
Sign up to save your podcasts
Or
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
4.1
9090 ratings
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
192 Listeners
95 Listeners
2,159 Listeners
981 Listeners
1,018 Listeners
279 Listeners
252 Listeners
176 Listeners
63 Listeners
1,281 Listeners
76 Listeners
25 Listeners
26 Listeners
24 Listeners
69 Listeners